Vascular Permeability Factor/Vascular Endothelial Growth Factor and the Significance of Microvascular Hyperpermeability in Angiogenesis
Abstract
This Chapter has reviewed the literature concerning VPF/VEGF as a potent vascular permeabilizing cytokine. In accord with this important role, microvessels have been found to be hyperpermeable to plasma proteins and other circulating macromolecules at sites where VPF/VEGF and its receptors are overexpressed, i.e., in tumors, healing wounds, retinopathies, many important inflammatory conditions and in certain physiological processes, such as ovulation and corpus luteum formation. Moreover, microvascular hyperpermeability to plasma proteins was shown to have an important consequence: the laying down of a fibrin-rich extracellular matrix. This provisional matrix, in turn, favors and supports the ingrowth of fibroblasts and endothelial cells which, together, transform the provisional matrix into the mature stroma characteristic of tumors and healed wounds. Finally, we have considered the pathways by which these and other circulating macromolecules cross the endothelium of normal and VPF/VEGF-permeabilized microvessels. These pathways include VVOs and trans-endothelial openings that have been variously interpreted as inter-endothelial cell gaps or trans-endothelial cell pores. At least some trans-endothelial cell pores may arise from VVOs. In conclusion, these data provide new insights into the mechanisms of angiogenesis and stroma formation, insights which are potentially applicable to a wide variety of disease states and which may lead to identification of new targets for therap…
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
VEGF can contribute to systemic intravasation by increasing microvascular permeability.
“VEGF can also contribute to systemic intravasation by increasing microvascular permeability (Claffey et al., 1996;Dvorak et al., 1999).”
From Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer (2016) · cites this paper as Dvorak et al., 1999
No citation lists for this paper
No citation lists for this paper yet — checked again daily.
References 175 · Cited by 743
- Authors
- Dvorak, H. F., Nagy, J. A., Feng, D., Brown, L. F., & Dvorak, A. M.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- ORCID
- Nagy, J. A.
- Venue
- Current Topics in Microbiology and Immunology
- Publisher
- Springer Berlin Heidelberg
- Published
- 1999
- Volume
- 237
- Pages
- 97-132
- ISSN
- 0070-217X (ISSN-L)
- OpenAlex
- W189480869
- Cited by
- 743
- References
- 175
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 9 · 2023: 9 · 2022: 21 · 2021: 15 · 2020: 18 · 2019: 20 · 2018: 17 · 2017: 12 · 2016: 16 · 2015: 21 · 2014: 16 · 2013: 39 · 2012: 23
- FWCI
- 46.96
- Type
- book chapter
- Language
- en
- Open access
- closed
- Locations
- Current topics in microbiology and immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Keywords
- vascular endothelial growth factor, microvascular hyperpermeability, angiogenesis, plasma protein leakage, wound healing, retinopathy, vascular occlusion, ovulation, corpus luteum formation, inflammatory diseases
- MeSH terms
- Animals, Capillary Permeability, Endothelium, Vascular, Humans, Lymphokines, Microscopy, Electron, Neoplasms, Neovascularization, Pathologic, Venules, Endothelial Growth Factors, Receptors, Growth Factor, Neovascularization, Physiologic, Receptor Protein-Tyrosine Kinases, Receptors, Vascular Endothelial Growth Factor, Vascular Endothelial Growth Factors, Vascular Endothelial Growth Factor A
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review